These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16315437)
1. DHEA supplementation: the claims in perspective. Olech E; Merrill JT Cleve Clin J Med; 2005 Nov; 72(11):965-6, 968, 970-1 passim. PubMed ID: 16315437 [TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. Kenny AM; Boxer RS; Kleppinger A; Brindisi J; Feinn R; Burleson JA J Am Geriatr Soc; 2010 Sep; 58(9):1707-14. PubMed ID: 20863330 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat. Meno-Tetang GM; Hon YY; Van Wart S; Jusko WJ Drug Metabol Drug Interact; 1999; 15(1):51-70. PubMed ID: 10707113 [TBL] [Abstract][Full Text] [Related]
4. [Replacement and supplementation of DHEA--is it a wellness hormone?]. Brückel J MMW Fortschr Med; 2005 Feb; 147(7):30-2. PubMed ID: 18441581 [TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. Barry NN; McGuire JL; van Vollenhoven RF J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429 [TBL] [Abstract][Full Text] [Related]
6. Oral dehydroepiandrosterone inhibits the growth of human pancreatic cancer in nude mice. Muscarella P; Boros LG; Fisher WE; Rink C; Melvin WS J Surg Res; 1998 Oct; 79(2):154-7. PubMed ID: 9758731 [TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. Kawano H; Yasue H; Kitagawa A; Hirai N; Yoshida T; Soejima H; Miyamoto S; Nakano M; Ogawa H J Clin Endocrinol Metab; 2003 Jul; 88(7):3190-5. PubMed ID: 12843164 [TBL] [Abstract][Full Text] [Related]
8. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649 [TBL] [Abstract][Full Text] [Related]
9. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Basu R; Dalla Man C; Campioni M; Basu A; Nair KS; Jensen MD; Khosla S; Klee G; Toffolo G; Cobelli C; Rizza RA Diabetes; 2007 Mar; 56(3):753-66. PubMed ID: 17327446 [TBL] [Abstract][Full Text] [Related]
10. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433 [TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone (DHEA). Med Lett Drugs Ther; 2005 May; 47(1208):37-8. PubMed ID: 15880085 [TBL] [Abstract][Full Text] [Related]
12. Human nutritional supplements in the horse. Dehydroepiandrosterone versus androstenedione: comparative effects on the androgen profile and consequences for doping analysis. Dehennin L; Bonnaire Y; Plou P J Anal Toxicol; 2001; 25(8):685-90. PubMed ID: 11765025 [TBL] [Abstract][Full Text] [Related]
13. DHEA and sport. Corrigan B Clin J Sport Med; 2002 Jul; 12(4):236-41. PubMed ID: 12131057 [TBL] [Abstract][Full Text] [Related]
14. Effect of dehydroepiandrosterone supplementation on fatty acid and hormone levels in patients with X-linked adrenoleucodystrophy. Assies J; Haverkort EB; Lieverse R; Vreken P Clin Endocrinol (Oxf); 2003 Oct; 59(4):459-66. PubMed ID: 14510908 [TBL] [Abstract][Full Text] [Related]
15. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids? Robinzon B; Cutolo M Rheumatology (Oxford); 1999 Jun; 38(6):488-95. PubMed ID: 10402066 [TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Hayashi T; Esaki T; Muto E; Kano H; Asai Y; Thakur NK; Sumi D; Jayachandran M; Iguchi A Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):782-92. PubMed ID: 10712404 [TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone supplementation combined with Weight-Loading Whole-Body Vibration Training (WWBV) affects exercise performance and muscle glycogen storage in middle-aged C57BL/6 mice. Chen YM; Lee HC; Chen MT; Huang CC; Chen WC Int J Med Sci; 2018; 15(6):564-573. PubMed ID: 29725246 [No Abstract] [Full Text] [Related]
18. Treatment of pouchitis with dehydroepiandrosterone (DHEA) - a case report. Klebl FH; Bregenzer N; Rogler G; Straub RH; Schölmerich J; Andus T Z Gastroenterol; 2003 Nov; 41(11):1087-90. PubMed ID: 14648378 [TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells. Coles AJ; Thompson S; Cox AL; Curran S; Gurnell EM; Chatterjee VK Eur J Immunol; 2005 Dec; 35(12):3694-703. PubMed ID: 16252254 [TBL] [Abstract][Full Text] [Related]